Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 263

1.

Transcytosis of Human immunodeficiency virus 1 across the placenta is enhanced by treatment with tumour necrosis factor alpha.

Parry S, Zhang J, Koi H, Arechavaleta-Velasco F, Elovitz MA.

J Gen Virol. 2006 Aug;87(Pt 8):2269-78.

PMID:
16847123
2.

Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis.

Ho JL, He S, Hu A, Geng J, Basile FG, Almeida MG, Saito AY, Laurence J, Johnson WD Jr.

J Exp Med. 1995 Apr 1;181(4):1493-505. Erratum in: J Exp Med 1999 Nov 1;190(9):following 1362.

3.
5.

R5- and X4-HIV-1 use differentially the endometrial epithelial cells HEC-1A to ensure their own spread: implication for mechanisms of sexual transmission.

Saïdi H, Magri G, Nasreddine N, Réquena M, Bélec L.

Virology. 2007 Feb 5;358(1):55-68. Epub 2006 Aug 24.

6.
7.

Syncytiotrophoblast is a barrier to maternal-fetal transmission of herpes simplex virus.

Koi H, Zhang J, Makrigiannakis A, Getsios S, MacCalman CD, Strauss JF 3rd, Parry S.

Biol Reprod. 2002 Nov;67(5):1572-9.

PMID:
12390890
8.

Progesterone inhibits HIV-1 replication in human trophoblast cells through inhibition of autocrine tumor necrosis factor secretion.

Muñoz LD, Serramía MJ, Fresno M, Muñoz-Fernández MA.

J Infect Dis. 2007 May 1;195(9):1294-302. Epub 2007 Mar 23.

PMID:
17396998
9.

Cell-to-cell contact results in a selective translocation of maternal human immunodeficiency virus type 1 quasispecies across a trophoblastic barrier by both transcytosis and infection.

Lagaye S, Derrien M, Menu E, Coïto C, Tresoldi E, Mauclère P, Scarlatti G, Chaouat G, Barré-Sinoussi F, Bomsel M; European Network for the Study of In Utero Transmission of HIV-1.

J Virol. 2001 May;75(10):4780-91.

11.

Productive human immunodeficiency virus-1 infection of epithelial cell lines of salivary gland origin.

Han Y, Ventura CL, Black KP, Cummins JE Jr, Hall SD, Jackson S.

Oral Microbiol Immunol. 2000 Apr;15(2):82-8.

PMID:
11155170
12.

Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV-1 replication.

Angel JB, Saget BM, Walsh SP, Greten TF, Dinarello CA, Skolnik PR, Endres S.

AIDS. 1995 Oct;9(10):1137-44.

PMID:
8519449
13.

Effects of intravenous immunoglobulin in vivo on abnormally increased tumor necrosis factor-alpha activity in human immunodeficiency virus type 1 infection.

Aukrust P, Hestdal K, Lien E, Bjerkeli V, Nordøy I, Espevik T, Müller F, Frøland SS.

J Infect Dis. 1997 Oct;176(4):913-23.

PMID:
9333149
14.

The effect of tenidap on cytokines, acute-phase proteins, and virus load in human immunodeficiency virus (HIV)-infected patients: correlation between plasma HIV-1 RNA and proinflammatory cytokine levels.

Dezube BJ, Lederman MM, Chapman B, Georges DL, Dogon AL, Mudido P, Reis-Lishing J, Cheng SL, Silberman SL, Crumpacker CS.

J Infect Dis. 1997 Sep;176(3):807-10.

PMID:
9291340
15.

Chorioamnionitis is associated with placental transmission of human immunodeficiency virus-1 subtype E in the early gestational period.

Bhoopat L, Khunamornpong S, Sirivatanapa P, Rithaporn T, Lerdsrimongkol P, Thorner PS, Bhoopat T.

Mod Pathol. 2005 Oct;18(10):1357-64.

16.

In vitro evidence for a dual role of tumor necrosis factor-alpha in human immunodeficiency virus type 1 encephalopathy.

Wilt SG, Milward E, Zhou JM, Nagasato K, Patton H, Rusten R, Griffin DE, O'Connor M, Dubois-Dalcq M.

Ann Neurol. 1995 Mar;37(3):381-94.

PMID:
7695238
17.

Alterations in mast cell function and survival following in vitro infection with human immunodeficiency viruses-1 through CXCR4.

Taub DD, Mikovits JA, Nilsson G, Schaffer EM, Key ML, Petrow-Sadowski C, Ruscetti FW.

Cell Immunol. 2004 Aug;230(2):65-80.

PMID:
15598422
20.

Supplemental Content

Support Center